Human Reproduction, Vol. 11, No. 6, pp. 1169-1172, 1996
© 1996 European Society of Human Reproduction and Embryology
research-article |
A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle stimulating hormone concentrations on day 3
Department of Obstetrics and Gynecology, A. Béclère Hospital 157 Rue de la Porte de Trivaux, 92140 Clamart, France
Correspondence: 1To whom correspondence should be addressed
We studied 98 in-vitro fertilization (IVF) patients with a high basal follicle stimulating hormone (FSH;>6.5 IU/I) concentration on day 3 who were treated with a low dose gonadotrophin-releasing hormone agonist (GnRHa) protocol and who had received in the previous 6 months a long protocol with GnRHa in a depot formula. The evaluation was made using the previous IVF cycle of the same patient as a control. The mean ± SD age of the patients was 34.1 ± 4.2 years. The use of a low dose agonist protocol ended with significantly less ampoules (37.5 versus 46.1), a shorter duration of stimulation (10.7 versus 12.3 days), a higher oestradiol concentration on day 8 (1068 versus 495 pg/ml), a higher number of mature oocytes (5.9 versus 4.4) and a higher number of good quality embryos (3.3 versus 2.3). The cancellation rate was lower (11 versus 24%). A GnRHa low dose protocol may be the protocol of choice for patients with high FSH concentrations on day 3. Larger randomized studies are needed to confirm these data.
Key words: GnRHa/low dose/poor responders
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Dal Prato, A. Borini, G. Coticchio, M. Cattoli, and C. Flamigni Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study Hum. Reprod., October 1, 2004; 19(10): 2200 - 2205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. De Placido, A. Mollo, C. Alviggi, I. Strina, M. T. Varricchio, A. Ranieri, N. Colacurci, A. Tolino, and M. Wilding Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH Hum. Reprod., September 1, 2001; 16(9): 1875 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.D. Prato, A. Borini, M.R. Trevisi, M.A. Bonu, E. Sereni, and C. Flamigni Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study Hum. Reprod., July 1, 2001; 16(7): 1409 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.M.J. Janssens, C.B. Lambalk, J.P.W. Vermeiden, R. Schats, J.M. Bernards, L.T.M. Rekers-Mombarg, and J. Schoemaker Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study Hum. Reprod., November 1, 2000; 15(11): 2333 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Devreker, E. Pogonici, V. De Maertelaer, P. Revelard, M. Van den Bergh, and Y. Englert Selection of good embryos for transfer depends on embryo cohort size: implications for the `mild ovarian stimulation' debate Hum. Reprod., December 1, 1999; 14(12): 3002 - 3008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Karande and N. Gleicher A rational approach to the management of low responders in in-vitro fertilization: Opinion Hum. Reprod., July 1, 1999; 14(7): 1744 - 1748. [Full Text] [PDF]
|
|